Technical Analysis for MRTX - Mirati Therapeutics, Inc.
| ADX | Long-Term | Intermediate-Term | Short-Term |
|---|---|---|---|
| Weak or Absent | Down | Down | Up |
| See historical MRTX trend table... | |||
| Date | Alert Name | Type | % Chg |
|---|---|---|---|
| Nov 16 | 20 DMA Support | Bullish | 0.00% |
| Nov 16 | Pocket Pivot | Bullish Swing Setup | 0.00% |
| Nov 16 | Multiple of Ten Bullish | Other | 0.00% |
| Nov 16 | Up 3 Days in a Row | Strength | 0.00% |
| Nov 15 | Bullish Engulfing | Bullish | 5.52% |
| Nov 15 | Crossed Above 20 DMA | Bullish | 5.52% |
| Nov 15 | NR7 | Range Contraction | 5.52% |
| Nov 14 | 20 DMA Resistance | Bearish | 9.97% |
| Nov 14 | Lizard Bullish | Bullish Day Trade Setup | 9.97% |
| Nov 14 | Pocket Pivot | Bullish Swing Setup | 9.97% |
Get a Trading Assistant
Let us help you stay on top of your investments. We will alert you to important technical developments on your
portfolio & watchlist.
Configure default chart indicators
Basic chart:
- Earnings date: 2018-11-07
Mirati Therapeutics Inc., a biopharmaceutical company, engages in the development of therapeutics for the cancer treatment. Its lead program in clinical development is MGCD265, a multi-targeted small molecule kinase inhibitor for treatment of oncology patients with solid tumors. The company also evaluates development opportunities in oncology for mocetinostat, a spectrum-selective HDAC inhibitor for the treatment of patients with myelodysplastic syndrome or lymphoma; and MGCD516, a kinase inhibitor with a target profile for the treatment of patients with non-small cell lung cancer and other solid tumors. Mirati Therapeutics Inc. is headquartered in San Diego, California.
| Indicator | Bull Case | Neutral / Hold | Bear Case |
|---|---|---|---|
| 50 DMA | |||
| 200 DMA | |||
| ADX Trend | |||
| Oversold / Overbought | |||
| Relative Strength | |||
| Summary: | Counts: 0 bullish, 2 bearish and 3 neutral indicators. You may wish to incorporate that into your trading strategies. | ||
See more MRTX news...
Indicators
| Indicator | Value |
|---|---|
| 52 Week High | 65.345 |
| 52 Week Low | 15.35 |
| Average Volume | 774,400 |
| 200-Day Moving Average | 42.3772 |
| 50-Day Moving Average | 44.6426 |
| 20-Day Moving Average | 37.5635 |
| 10-Day Moving Average | 39.32 |
| Average True Range | 3.3176 |
| ADX | 24.61 |
| +DI | 21.8735 |
| -DI | 24.2508 |
| Chandelier Exit (Long, 3 ATRs ) | 34.5372 |
| Chandelier Exit (Short, 3 ATRs ) | 38.4528 |
| Upper Bollinger Band | 42.7535 |
| Lower Bollinger Band | 32.3735 |
| Percent B (%b) | 0.83 |
| BandWidth | 27.633208 |
| MACD Line | -1.1514 |
| MACD Signal Line | -1.8278 |
| MACD Histogram | 0.6764 |
| Fundamentals | Value |
|---|---|
| Market Cap | 1.02 Billion |
| Num Shares | 25 Million |
| EPS | -3.38 |
| Price-to-Earnings (P/E) Ratio | -12.11 |
| Price-to-Sales | 0.00 |
| Price-to-Book | 3.81 |
| PEG Ratio | 0.00 |
| Dividend | 0.00 |
| Dividend Yield | 0.00% |
| Pivot Point Level | Traditional / Classic | Fibonacci | Demark | Woodie | Camarilla |
|---|---|---|---|---|---|
| Resistance 4 (R4) | 46.67 | ||||
| Resistance 3 (R3) | 46.17 | 43.75 | 45.72 | ||
| Resistance 2 (R2) | 43.75 | 42.29 | 44.01 | 45.40 | |
| Resistance 1 (R1) | 42.35 | 41.39 | 43.05 | 42.85 | 45.08 |
| Pivot Point | 39.93 | 39.93 | 40.29 | 40.19 | 39.93 |
| Support 1 (S1) | 38.53 | 38.47 | 39.23 | 39.03 | 36.80 |
| Support 2 (S2) | 36.11 | 37.57 | 36.37 | 36.48 | |
| Support 3 (S3) | 34.71 | 36.11 | 36.17 | ||
| Support 4 (S4) | 35.21 |
